New research out of the University of Maryland report a new way to “turn off” immune attacks associated with multiple sclerosis.
The team is working to reprogram the function of lymph nodes by instructing to promote regulatory immune cells instead of generating inflammatory cells that attack myelin.
According to Medical Xpress collaborator Jonathan Bromberg, MD, PhD, a professor of surgery at the University of Maryland School of Medicine said, “The studies show it is possible to treat and cure inflammatory disease with a single dose of therapeutics loaded in biodegradable polymers targeted directly to lymph nodes – the tissues that coordinate immune function in the body.”
The team is testing this by using two rodent models of MS and the results are promising.
“This innovative research has the potential to open up a new, highly selective approach to treating multiple sclerosis,” said Bruce F. Bebo, Ph.D., Executive Vice President of Research at the National Multiple Sclerosis Society.
Are you optimistic about this new research?